摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,8-dichloro-2H-benzo[b][1,4]oxazin-3(4H)-one | 87571-80-0

中文名称
——
中文别名
——
英文名称
6,8-dichloro-2H-benzo[b][1,4]oxazin-3(4H)-one
英文别名
6,8-dichloro-4H-benzo[1,4]oxazin-3-one;6,8-dichloro-4H-benz[1,4]oxazin-3-one;6,8-Dichlor-4H-benz[1,4]oxazin-3-on;6,8-dichloro-4H-1,4-benzoxazin-3-one
6,8-dichloro-2H-benzo[b][1,4]oxazin-3(4H)-one化学式
CAS
87571-80-0
化学式
C8H5Cl2NO2
mdl
——
分子量
218.039
InChiKey
NHULZNDEJMIUNY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    385.5±42.0 °C(Predicted)
  • 密度:
    1.516±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6,8-dichloro-2H-benzo[b][1,4]oxazin-3(4H)-one 在 6-chloro-3-((dimethylamino)(dimethyliminio)methyl)-1H-benzo[d][1,2,3]triazol-3-ium-1-olatehexafluorophosphate(V) 、 potassium carbonateN,N-二异丙基乙胺 、 lithium hydroxide 作用下, 以 四氢呋喃二甲基亚砜N,N-二甲基甲酰胺 为溶剂, 反应 20.0h, 生成 4-(3-(6,8-dichloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)propanoyl)-N-phenylpiperazine-1-carboxamide
    参考文献:
    名称:
    苯并[b] [1,4]恶嗪-3(4H)-one作为分支杆菌胸苷酸合酶X抑制剂的类似物的合成及构效关系研究。
    摘要:
    由于发现了人类中不存在的黄素依赖性胸苷酸合酶(ThyX或FDTS),但对于多种病原体中的DNA生物合成至关重要,该酶一直被用于开发针对结核分枝杆菌的新型抗菌剂。广泛的传染病结核病(TB)的病原体。为了响应对更有效的抗结核药物的日益增长的需求,我们在之前的筛选工作基础上,在此报告了一系列具有独特抑制谱的新型抑制剂的优化方案。抑制剂对ThyX的亚甲基四氢叶酸辅因子表现出竞争性抑制作用,使我们能够生成与目标结合的化合物模型,从而深入了解其结构与活性之间的关系。
    DOI:
    10.1002/cmdc.201800739
  • 作为产物:
    参考文献:
    名称:
    Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors
    摘要:
    Previous efforts have led to the identification of a potent, selective, and nonphlorizin based SGLT2 inhibitor 1. This Letter describes efforts to further optimize the potency, microsomal stability, solubility and pharmacokinetic properties of this series of SGLT2 inhibitors. From these efforts, compounds 28 and 32 have improved solubility and pharmacokinetic properties compared to compound 1 (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.04.053
点击查看最新优质反应信息

文献信息

  • The chemistry of plant-growth regulators. Part I. 2 : 4-Dichloro-6-hydroxyphenoxyacetic acid and related compounds
    作者:G. W. K. Cavill、D. L. Ford
    DOI:10.1039/jr9540000565
    日期:——
  • Discovery of non-glucoside SGLT2 inhibitors
    作者:An-Rong Li、Jian Zhang、Joanne Greenberg、TaeWeon Lee、Jiwen Liu
    DOI:10.1016/j.bmcl.2011.02.056
    日期:2011.4
    A series of benzothiazinone and benzooxazinone derivatives were discovered as SGLT2 inhibitors. The optimization led to the discovery of compounds 31 and 32, which exhibited similar potency and better SGLT1 selectivity compared to dapagliflozin. These compounds may provide novel promising scaffolds, which are different from phlorizin-based SGLT2 inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.
  • Optimization of triazoles as novel and potent nonphlorizin SGLT2 inhibitors
    作者:Xiaohui Du、Mike Lizarzaburu、Simon Turcotte、Taeweon Lee、Joanne Greenberg、Bei Shan、Peter Fan、Yun Ling、Julio C. Medina、Jonathan Houze
    DOI:10.1016/j.bmcl.2011.04.053
    日期:2011.6
    Previous efforts have led to the identification of a potent, selective, and nonphlorizin based SGLT2 inhibitor 1. This Letter describes efforts to further optimize the potency, microsomal stability, solubility and pharmacokinetic properties of this series of SGLT2 inhibitors. From these efforts, compounds 28 and 32 have improved solubility and pharmacokinetic properties compared to compound 1 (C) 2011 Elsevier Ltd. All rights reserved.
  • Synthesis and Structure–Activity Relationship Studies of Benzo[ <i>b</i> ][1,4]oxazin‐3(4 <i>H</i> )‐one Analogues as Inhibitors of Mycobacterial Thymidylate Synthase X
    作者:Jakub Modranka、Jiahong Li、Anastasia Parchina、Michiel Vanmeert、Shrinivas Dumbre、Mayla Salman、Hannu Myllykallio、Hubert F. Becker、Roeland Vanhoutte、Lia Margamuljana、Hoai Nguyen、Rania Abu El‐Asrar、Jef Rozenski、Piet Herdewijn、Steven De Jonghe、Eveline Lescrinier
    DOI:10.1002/cmdc.201800739
    日期:2019.3.22
    report herein an optimization campaign of a novel series of inhibitors with a unique inhibition profile. The inhibitors display competitive inhibition toward the methylene tetrahydrofolate cofactor of ThyX, enabling us to generate a model of the compounds bound to their target, thus offering insight into their structure-activity relationships.
    由于发现了人类中不存在的黄素依赖性胸苷酸合酶(ThyX或FDTS),但对于多种病原体中的DNA生物合成至关重要,该酶一直被用于开发针对结核分枝杆菌的新型抗菌剂。广泛的传染病结核病(TB)的病原体。为了响应对更有效的抗结核药物的日益增长的需求,我们在之前的筛选工作基础上,在此报告了一系列具有独特抑制谱的新型抑制剂的优化方案。抑制剂对ThyX的亚甲基四氢叶酸辅因子表现出竞争性抑制作用,使我们能够生成与目标结合的化合物模型,从而深入了解其结构与活性之间的关系。
查看更多